LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 3 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,730 | +591.7% | 100,200 | +610.6% | 0.01% | +1000.0% |
| Q2 2023 | $973 | -51.1% | 14,100 | -65.9% | 0.00% | -66.7% |
| Q1 2023 | $1,991 | +29.0% | 41,300 | +33.7% | 0.00% | +50.0% |
| Q4 2022 | $1,543 | -99.9% | 30,900 | -56.0% | 0.00% | -50.0% |
| Q3 2022 | $2,864,000 | -56.5% | 70,200 | -61.2% | 0.00% | -50.0% |
| Q1 2022 | $6,581,000 | +163.7% | 181,100 | +197.9% | 0.01% | +166.7% |
| Q2 2021 | $2,496,000 | – | 60,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |